Mariya Pylypiv - Oct 20, 2021 Form 4 Insider Report for UpHealth, Inc. (UPH)

Signature
By: Mariya Pylypiv
Stock symbol
UPH
Transactions as of
Oct 20, 2021
Transactions value $
$102,168
Form type
4
Date filed
11/19/2021, 04:47 PM
Previous filing
Jun 11, 2021
Next filing
Aug 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UPH Common Stock Award $0 +155K +2.08% $0.00 7.62M Oct 20, 2021 Direct F1
transaction UPH Common Stock Purchase $8.9K +2.62K +0.03% $3.40 7.62M Nov 17, 2021 Direct
transaction UPH Common Stock Purchase $34.2K +10K +0.13% $3.42 7.63M Nov 17, 2021 Direct
transaction UPH Common Stock Purchase $2.16K +645 +0.01% $3.35 7.63M Nov 18, 2021 Direct
transaction UPH Common Stock Purchase $56.9K +16.7K +0.22% $3.40 7.65M Nov 18, 2021 Direct
holding UPH Common Stock 7.46M Oct 20, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UPH Performance-Based Restricted Stock Unit Award $0 +155K $0.00 155K Oct 20, 2021 Common Stock 155K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person's continued service to UpHealth, Inc. (the "Company"), 1/3 of the Restricted Stock Unit ("RSUs") shall vest on May 1, 2022 (the "Initial Vesting Date"), and the remaining 2/3 of the RSUs shall vest quarterly on each of three month anniversary following the Initial Vesting Date until fully vested.
F2 Each performance-based RSU represents the right to receive, following vesting, one share of the Company's common stock ("Common Stock"). The number of shares of Common Stock acquired upon vesting of the performance-based RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Board of Directors on an annual basis over three one-year performance periods beginning on the first day of the fiscal year of 2021 and ending on the last day of the fiscal year of 2023.